PHK Development Brings Hacker-Designed Seven-Story Condo to Portland’s Inner East Side
Apr 03, 2018 21:30 pm UTC| Business
PORTLAND, Ore., April 03, 2018 -- Portland’s Inner Eastside neighborhood is getting its first new, class-A residential condominium development in more than a decade. TwentyTwenty, at NE 21st Avenue and Multnomah, is a...
RMG Networks Holding Corporation Agrees to be Acquired by SCG Digital, LLC
Apr 03, 2018 21:15 pm UTC| Business
DALLAS, April 03, 2018 -- RMG Networks Holding Corporation (NASDAQ:RMGN), or RMG, a global leader in technology-driven visual communications, and SCG Digital, LLC, announced today the execution of a definitive merger...
Nightstar Therapeutics Reports 2017 Financial Results and Business Highlights
Apr 03, 2018 21:15 pm UTC| Business
- Recent initiation of STAR phase 3 trial in Choroideremia - - Begins 2018 with a cash position over $129 million - LEXINGTON, Mass. and LONDON, April 03, 2018 -- Nightstar Therapeutics plc (NASDAQ:NITE), a...
New Patient-Centered Program Launched for New York Primary Care Practices
Apr 03, 2018 21:14 pm UTC| Business
WASHINGTON, DC, April 03, 2018 -- The National Committee for Quality Assurance (NCQA), creator of the nation’s leading patient-centered medical home (PCMH) program, collaborated with the New York State Department of...
Range Announces Conference Call to Discuss First Quarter 2018 Financial Results
Apr 03, 2018 21:05 pm UTC| Business
FORT WORTH, Texas, April 03, 2018 -- RANGE RESOURCES CORPORATION (NYSE:RRC) announced today that its first quarter 2018 financial results news release will be issued Wednesday, April 25 after the close of trading on the...
Apr 03, 2018 21:04 pm UTC| Business
Santa Monica, April 03, 2018 -- Organizers of the Advanced Clean Transportation (ACT) Expo, North America’s leading conference and expo on real-world applications of the latest advanced transportation technologies,...
Apr 03, 2018 21:00 pm UTC| Business
CAMBRIDGE, Mass., April 03, 2018 -- Unum Therapeutics Inc. (“Unum Therapeutics”) (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products designed to harness...